Performance of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA Quantification
- 1 May 2008
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (5), 1716-1723
- https://doi.org/10.1128/jcm.01248-07
Abstract
Hepatitis B virus (HBV) DNA quantification is used to establish the prognosis of chronic HBV-related liver disease, to identify those patients who need to be treated, and to monitor the virologic response and resistance to antiviral therapies. Real-time PCR-based assays are gradually replacing other technologies for routine quantification of HBV DNA in clinical practice. The goal of this study was to evaluate the intrinsic characteristics and clinical performance of the real-time PCR Cobas AmpliPrep/Cobas TaqMan (CAP/CTM) platform for HBV DNA quantification. Specificity was satisfactory (95% confidence interval, 98.1 to 100%). Intra-assay coefficients of variation ranged from 0.22% to 2.68%, and interassay coefficients of variation ranged from 1.31% to 4.13%. Quantification was linear over the full dynamic range of quantification of the assay (1.7 to 8.0 log 10 IU/ml) and was not affected by dilution. The assay was accurate regardless of the HBV genotype. Samples containing HBV DNA levels above 4.5 log 10 IU/ml were slightly underestimated relative to another accurate assay based on branched-DNA technology, but this is unlikely to have noteworthy clinical implications. Thus, the CAP/CTM HBV DNA assay is sensitive, specific, and reproducible, and it accurately quantifies HBV DNA levels in patients chronically infected by HBV genotypes A to F. Samples with HBV DNA concentrations above the upper limit of quantification need to be diluted and then retested. Broad use of fully automated real-time PCR assays should improve the management of patients with chronic HBV infection.Keywords
This publication has 18 references indexed in Scilit:
- COBAS AmpliPrep-COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real-Time PCR Assay for Quantification of HBV DNA in PlasmaJournal of Clinical Microbiology, 2007
- A Genotype-Independent Real-Time PCR Assay for Quantification of Hepatitis B Virus DNAJournal of Clinical Microbiology, 2007
- Fully automated quantitation of Hepatitis B virus (HBV) DNA in human plasma by the COBAS® AmpliPrep/COBAS® TaqMan® SystemJournal of Clinical Virology, 2006
- Evaluation of the COBAS AmpliPrep-Total Nucleic Acid Isolation-COBAS TaqMan Hepatitis B Virus (HBV) Quantitative Test and Comparison to the VERSANT HBV DNA 3.0 AssayJournal of Clinical Microbiology, 2006
- Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysisJournal of Hepatology, 2004
- Fully Automated, Internally Controlled Quantification of Hepatitis B Virus DNA by Real-Time PCR by Use of the MagNA Pure LC and LightCycler InstrumentsJournal of Clinical Microbiology, 2004
- Quality control in nucleic acid testing—where do we stand?Journal of Clinical Virology, 2002
- Is there a formula for an effective CMV vaccine?Journal of Clinical Virology, 2002
- An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniquesVox Sanguinis, 2001
- Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistanceHepatology, 1999